glp-1 kidney protection agonists in the treatment of chronic disease in type 2 diabetes and obesity Kidney-Protection Benefits of Metabolic Surgery

The Ozempic response was filed with the Panel on December 29, 2023

Controlled environments in animal laboratories cannot recapitulate the complexity of real-world clinical settings

Ross closes on what England can realistically do tactically to respect the physiology.LinksThe Guardian article on England's foiled smash-and-grab paradigm, fortunately for them!This is the study I've seen cited in support of the late-arrival theory, even though its conclusion actually refutes the advantage!A study showing that you only get better, over 6h, 17h and then 48h, so get in as soon as you canAnother one, this time over longer time frames, looking at how we improve with more time at altitudeBrosnan study on repeat sprint interactions with altitude and rest period Durability - Trialled, Tested and Explained / Werro Edges Closer to the World Record / The World Cup's Extra-Time Problem / TDF and Heat Fears 01:11:04|Become a member of the Real Science of Sport

1996 Jan 16;61(1)1-18

Contract development and manufacturing organizations (CDMOs) have rapidly expanded peptide synthesis capabilities to capture the GLP-1 opportunity

Apparently naming a tiny serving is a lot like naming a tiny penis